Goldman Sachs’s CorMedix CRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.42M Buy
196,601
+16,803
+9% +$207K ﹤0.01% 3291
2025
Q1
$1.11M Sell
179,798
-19,122
-10% -$118K ﹤0.01% 3744
2024
Q4
$1.61M Buy
198,920
+63,532
+47% +$515K ﹤0.01% 3633
2024
Q3
$1.09M Buy
135,388
+64,598
+91% +$522K ﹤0.01% 3704
2024
Q2
$307K Buy
70,790
+29,077
+70% +$126K ﹤0.01% 4204
2024
Q1
$177K Buy
41,713
+4,663
+13% +$19.8K ﹤0.01% 4363
2023
Q4
$139K Sell
37,050
-5,873
-14% -$22.1K ﹤0.01% 4406
2023
Q3
$159K Buy
42,923
+31,942
+291% +$118K ﹤0.01% 4306
2023
Q2
$43.5K Buy
+10,981
New +$43.5K ﹤0.01% 4685
2022
Q3
Sell
-26,193
Closed -$105K 5503
2022
Q2
$105K Sell
26,193
-19,449
-43% -$78K ﹤0.01% 5098
2022
Q1
$250K Sell
45,642
-21,717
-32% -$119K ﹤0.01% 4975
2021
Q4
$306K Buy
67,359
+35,751
+113% +$162K ﹤0.01% 4773
2021
Q3
$147K Buy
31,608
+4,999
+19% +$23.2K ﹤0.01% 4971
2021
Q2
$183K Sell
26,609
-34,872
-57% -$240K ﹤0.01% 4947
2021
Q1
$614K Buy
61,481
+42,022
+216% +$420K ﹤0.01% 4222
2020
Q4
$145K Buy
19,459
+9,196
+90% +$68.5K ﹤0.01% 4373
2020
Q3
$62K Buy
+10,263
New +$62K ﹤0.01% 4295
2019
Q3
Sell
-28,036
Closed -$251K 4240
2019
Q2
$251K Sell
28,036
-95,659
-77% -$856K ﹤0.01% 3781
2019
Q1
$1.17M Buy
+123,695
New +$1.17M ﹤0.01% 3189
2017
Q1
Sell
-7,020
Closed -$54K 4418
2016
Q4
$54K Sell
7,020
-8,743
-55% -$67.3K ﹤0.01% 4221
2016
Q3
$199K Buy
15,763
+885
+6% +$11.2K ﹤0.01% 3937
2016
Q2
$148K Buy
14,878
+5,752
+63% +$57.2K ﹤0.01% 3981
2016
Q1
$121K Buy
+9,126
New +$121K ﹤0.01% 3971
2015
Q4
Sell
-4,598
Closed -$46K 4482
2015
Q3
$46K Sell
4,598
-6,138
-57% -$61.4K ﹤0.01% 4352
2015
Q2
$208K Buy
10,736
+5,858
+120% +$113K ﹤0.01% 3987
2015
Q1
$240K Buy
4,878
+2,611
+115% +$128K ﹤0.01% 3774
2014
Q4
$22K Sell
2,267
-8
-0.4% -$78 ﹤0.01% 4470
2014
Q3
$21K Buy
2,275
+178
+8% +$1.64K ﹤0.01% 4453
2014
Q2
$19K Sell
2,097
-1,383
-40% -$12.5K ﹤0.01% 4356
2014
Q1
$44K Buy
+3,480
New +$44K ﹤0.01% 4242